Life Sciences
Sort by: Featured Most recent Most read Most commented
96 results total, viewing 11 - 20
Astro-Med profit drops 5.6% in 2Q
Profit for Astro-Med Inc. dropped 5.6 percent to $987,000, or 13 cents per diluted share, during the second quarter of 2012, compared with $1.05 million, or 14 cents per diluted share, during the second quarter of 2011. more
| 8/22/12 | 1 comment
Norman Prince Neurosciences Institute lands $600K for brain research, lecture series
The Norman Prince Neurosciences Institute at Rhode Island Hospital was awarded three philanthropic gifts totaling nearly $600,000 to improve brain science in the state of Rhode Island by supporting research and establishing a lecture series. more
R.I. to receive $648K in Pfizer settlement
Rhode Island is set to receive $647,722 as part of a $42.9 million national settlement with drug maker Pfizer Inc. for the unlawful promotion of its drugs Zyvox and Lyrica. more
| 12/12/12
IlluminOss’ bone-repair system excites investors
For the past year venture capitalists have kept a watchful eye on surgeries like the broken-ankle repair Dr. Thomas Gausepohl performed on a woman in Marl, Germany, in June 2011. more

By Patrick Anderson
PBN Staff Writer | 10/22/12

Covidien’s Mallinckrodt completes CNS Therapeutics acquisition
Medical device maker Covidien PLC’s pharmaceutical arm, Mallinckrodt, has completed its acquisition of St. Paul, Minn.-based CNS Therapeutics Inc. for roughly $100 million. more
| 10/3/12
Covidien completes Oridion acquisition
Medical device maker Covidien PLC has completed its acquisition of Oridion Systems Ltd., the company announced Tuesday. more
| 6/27/12
UMass Dartmouth professor lands $400K for cell imaging research
Maolin Guo, associate professor of chemistry and biochemistry at the University of Massachusetts Dartmouth, landed a $400,000 research grant from the National Science Foundation to support the development of a molecular imaging probe for cell research. more
| 12/3/12
Covidien lands added FDA approval for LigaSure
Covidien PLC has received 510(k) clearance from the U.S. Food and Drug Administration to use its LigaSure curved, small jaw, open sealer/divider in ear, nose and throat procedures. more
| 9/11/12
EpiVax awarded $55,000 to explore nerve disease treatment
Providence-based EpiVax Inc. was awarded a $55,000 grant from the GBS/CIDP Foundation International to explore using Tregitopes as a new therapy for a nerve disease that is treated currently with intravenous immunoglobulin. more
Amgen sales rise to $4.2B in 3Q
Thousand Oaks, Calif.–based Amgen, one of the world’s largest biotechnology companies, saw revenue rise 9.5 percent to $4.3 billion in the three months ended Sept. 30 from $3.9 billion during the same period in 2011. more
| 10/24/12
« Prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 … 10 | Next »
Calendar
PBN Hosted
Events

The 2nd Annual Healthiest Employers event will recognize employers who have strong, effective Health and Wellness programs in the region. Deadline for enrollment is June 28th.
Advertisement
National
Local
Latest News